Some studies have shown NF-κB’s ability to promote inflammation-associated cancer and inhibition of its signaling pathway in hepatocytes attenuates the onset of HCC associated with inflammation [61,62]. The gene discussed is NFKB1; the disease is hepatocellular carcinoma.